Financial & Tax Architects, LLC Novo Nordisk A S Transaction History

Financial & Tax Architects, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$122.71 - $146.91 $127,495 - $152,639	1,039 Added 35.2%	3,991 $570 Million
Q1 2024 May 08, 2024	BUY	$102.11 - $135.92 $301,428 - $401,235	2,952 New	2,952 $379 Million
Q4 2021 Aug 25, 2023	SELL	$95.88 - $117.08 $420,721 - $513,747	-4,388 Closed	0 $0
Q3 2021 Aug 25, 2023	BUY	$84.42 - $106.62 $370,434 - $467,848	4,388 New	4,388 $421 Million
Q2 2021 Aug 25, 2023	SELL	$67.66 - $84.76 $347,163 - $434,903	-5,131 Closed	0 $0
Q1 2021 Aug 25, 2023	BUY	$67.06 - $75.82 $344,084 - $389,032	5,131 New	5,131 $346 Million

1,955

320M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $246B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Financial & Tax Architects, LLC, based on Form 13F filings with the SEC.

Stay updated on Financial & Tax Architects, LLC with notifications on news.